The clinical efficacy of banazapril accompanied with metoprolol for treatment of congestive heart failure
Guohua Liu
Abstract
Guohua Liu
Abstract
Objective:To evaluate the clini ca l therapeutic efficacy of banazapril accompanied with metoprolol for treatment o f congestive heart failure (CHF).Method:Two hundred patients with CHF were randomized to ta ke banazapril (5~10 mg per day)and metopolol( 6.25~100 mg per day,n=50) and to placebo (n=100) on the basis of conventional treatment. The mean peri ods of follow up was 327 days and the efficacy was assessed by meaans of echocar diography and clinical symptoms.Result:There were more signficant improvement in NYHA func tional class in banazapril accompanied with metoprolol group than in placeebo gr oup. Banazapril and metoprolol were associated with greater overall reduction o f left ventricular end-diastolic diameter and an overall increase in the LVEF% during the first year of therapy.Conclusion:Long term addition of banazapril and metoprolol to standard therapy may profoundly improve cardiac function and prevent clinica l deterioration in patients with CHF when compared with patients without metopro lol and banazapril treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the clini ca l therapeutic efficacy of banazapril accompanied with metoprolol for treatment o f congestive heart failure (CHF).Method:Two hundred patients with CHF were randomized to ta ke banazapril (5~10 mg per day)and metopolol( 6.25~100 mg per day,n=50) and to placebo (n=100) on the basis of conventional treatment. The mean peri ods of follow up was 327 days and the efficacy was assessed by meaans of echocar diography and clinical symptoms.Result:There were more signficant improvement in NYHA func tional class in banazapril accompanied with metoprolol group than in placeebo gr oup. Banazapril and metoprolol were associated with greater overall reduction o f left ventricular end-diastolic diameter and an overall increase in the LVEF% during the first year of therapy.Conclusion:Long term addition of banazapril and metoprolol to standard therapy may profoundly improve cardiac function and prevent clinica l deterioration in patients with CHF when compared with patients without metopro lol and banazapril treatment.
Key concepts: Metoprolol, Medicine, Heart failure, Ejection fraction, Cardiology, Internal medicine, Placebo, Clinical efficacy